Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

References for PMC Articles for PubMed (Select 20713849)

1.

Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies.

Kotsopoulos J, Tworoger SS, Campos H, Chung FL, Clevenger CV, Franke AA, Mantzoros CS, Ricchiuti V, Willett WC, Hankinson SE, Eliassen AH.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):938-46. doi: 10.1158/1055-9965.EPI-09-1318. Epub 2010 Mar 23. Erratum in: Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1805.

2.

Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):927-31. doi: 10.1158/1055-9965.EPI-09-1121. Epub 2010 Mar 23.

3.

Meta-analysis of vitamin D, calcium and the prevention of breast cancer.

Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H.

Breast Cancer Res Treat. 2010 Jun;121(2):469-77. doi: 10.1007/s10549-009-0593-9. Epub 2009 Oct 23.

PMID:
19851861
4.

Vitamin D and non-Hodgkin lymphoma risk in adults: a review.

Kelly JL, Friedberg JW, Calvi LM, van Wijngaarden E, Fisher SG.

Cancer Invest. 2009 Nov;27(9):942-51. doi: 10.3109/07357900902849632. Review.

5.

Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer.

Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N.

J Clin Oncol. 2009 Aug 10;27(23):3757-63. doi: 10.1200/JCO.2008.20.0725. Epub 2009 May 18.

6.

Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma.

Ng AC, Kumar SK, Rajkumar SV, Drake MT.

Am J Hematol. 2009 Jul;84(7):397-400. doi: 10.1002/ajh.21412.

7.

Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk.

Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H.

Aliment Pharmacol Ther. 2009 Jul 1;30(2):113-25. doi: 10.1111/j.1365-2036.2009.04022.x. Epub 2009 Apr 15.

PMID:
19392870
8.

High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy.

Crew KD, Shane E, Cremers S, McMahon DJ, Irani D, Hershman DL.

J Clin Oncol. 2009 May 1;27(13):2151-6. doi: 10.1200/JCO.2008.19.6162. Epub 2009 Apr 6.

9.

A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers.

Lim U, Freedman DM, Hollis BW, Horst RL, Purdue MP, Chatterjee N, Weinstein SJ, Morton LM, Schatzkin A, Virtamo J, Linet MS, Hartge P, Albanes D.

Int J Cancer. 2009 Feb 15;124(4):979-86. doi: 10.1002/ijc.23984.

10.

Nonclassic actions of vitamin D.

Bikle D.

J Clin Endocrinol Metab. 2009 Jan;94(1):26-34. doi: 10.1210/jc.2008-1454. Epub 2008 Oct 14. Review.

11.

25-hydroxyvitamin D levels and the risk of mortality in the general population.

Melamed ML, Michos ED, Post W, Astor B.

Arch Intern Med. 2008 Aug 11;168(15):1629-37. doi: 10.1001/archinte.168.15.1629.

12.

Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer.

Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, Giovannucci EL, Fuchs CS.

J Clin Oncol. 2008 Jun 20;26(18):2984-91. doi: 10.1200/JCO.2007.15.1027.

13.

Correlation among 25-hydroxy-vitamin D assays.

Binkley N, Krueger D, Gemar D, Drezner MK.

J Clin Endocrinol Metab. 2008 May;93(5):1804-8. doi: 10.1210/jc.2007-2340. Epub 2008 Mar 4.

PMID:
18319318
14.

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.

Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M, Reiser M, Metzner B, Einsele H, Peter N, Jung W, Wörmann B, Ludwig WD, Dührsen U, Eimermacher H, Wandt H, Hasford J, Hiddemann W, Unterhalt M; German Low Grade Lymphoma Study Group (GLSG); European Mantle Cell Lymphoma Network.

Blood. 2008 Jan 15;111(2):558-65. Epub 2007 Oct 25. Erratum in: Blood. 2008 Jun 15;111(12):5761.

15.

Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium.

Kricker A, Armstrong BK, Hughes AM, Goumas C, Smedby KE, Zheng T, Spinelli JJ, De Sanjosé S, Hartge P, Melbye M, Willett EV, Becker N, Chiu BC, Cerhan JR, Maynadié M, Staines A, Cocco P, Boffeta P; Interlymph Consortium.

Int J Cancer. 2008 Jan 1;122(1):144-54.

PMID:
17708556
16.

Vitamin D deficiency.

Holick MF.

N Engl J Med. 2007 Jul 19;357(3):266-81. Review. No abstract available.

PMID:
17634462
17.

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.

Habermann TM, Weller EA, Morrison VA, Gascoyne RD, Cassileth PA, Cohn JB, Dakhil SR, Woda B, Fisher RI, Peterson BA, Horning SJ.

J Clin Oncol. 2006 Jul 1;24(19):3121-7. Epub 2006 Jun 5.

18.

Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.

Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC.

J Natl Cancer Inst. 2006 Apr 5;98(7):451-9.

19.

High prevalence of vitamin D inadequacy and implications for health.

Holick MF.

Mayo Clin Proc. 2006 Mar;81(3):353-73. Review.

PMID:
16529140
20.

Vitamin D and prevention of colorectal cancer.

Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, Newmark HL, Giovannucci E, Wei M, Holick MF.

J Steroid Biochem Mol Biol. 2005 Oct;97(1-2):179-94. Epub 2005 Oct 19.

PMID:
16236494
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk